✦ LIBER ✦

Preclinical evaluation of nanoparticle albumin-bound paclitaxel for treatment of pediatric bone sarcoma

✍ Scribed by Wagner, Lars M.; Yin, Hong; Eaves, David; Currier, Mark; Cripe, Timothy P.

Book ID: 121731854
Publisher: John Wiley and Sons
Year: 2014
Tongue: English
Weight: 145 KB
Volume: 61
Category: Article
ISSN: 1545-5009
DOI: 10.1002/pbc.25062

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Targeted delivery for breast cancer ther

Targeted delivery for breast cancer therapy: the history of nanoparticle-albumin-bound paclitaxel

✍ Petrelli, Fausto; Borgonovo, Karen; Barni, Sandro 📂 Article 📅 2010 🏛 Informa plc 🌐 English ⚖ 454 KB

Nanoparticle albumin-bound paclitaxel fo

Nanoparticle albumin-bound paclitaxel for second-line treatment of metastatic urothelial carcinoma: a single group, multicentre, phase 2 study

✍ Ko, Yoo-Joung; Canil, Christine M; Mukherjee, Som D; Winquist, Eric; Elser, Chri 📂 Article 📅 2013 🏛 The Lancet 🌐 English ⚖ 210 KB

Enhancing intracellular taxane delivery:

Enhancing intracellular taxane delivery: current role and perspectives of nanoparticle albumin-bound paclitaxel in the treatment of advanced breast cancer

✍ Guarneri, Valentina; Dieci, Maria Vittoria; Conte, PierFranco 📂 Article 📅 2012 🏛 Informa plc 🌐 English ⚖ 306 KB

Enhancing intracellular taxane delivery:

Enhancing intracellular taxane delivery: current role and perspectives of nanoparticle albumin-bound paclitaxel in the treatment of advanced breast cancer

✍ Guarneri, Valentina; Dieci, Maria Vittoria; Conte, PierFranco 📂 Article 📅 2012 🏛 Informa plc 🌐 English ⚖ 306 KB

## Introduction: Docetaxel and paclitaxel are among the most active agents for the treatment of breast cancer. these first-generation taxanes are extremely hydrophobic; therefore, solvents are needed for its parenteral administration. albumin nanoparticle technology allows for the transportation of

1696 PHASE I/II TRIAL OF INTRAVESICAL NA

1696 PHASE I/II TRIAL OF INTRAVESICAL NANOPARTICLE ALBUMIN- BOUND PACLITAXEL FOR THE TREATMENT OF BCG REFRACTORY NON-MUSCLE INVASIVE TRANSITIONAL CELL CARCINOMA

✍ Holder, Dara; Castaneda, Crystal; Ahn, Jennifer; Badalato, Gina; Barlow, LaMont; 📂 Article 📅 2013 🏛 Lippincott Williams and Wilkins 🌐 English ⚖ 103 KB

Preclinical Evaluation of Genexol-PM, a

Preclinical Evaluation of Genexol-PM, a Nanoparticle Formulation of Paclitaxel, as a Novel Radiosensitizer for the Treatment of Non-Small Cell Lung Cancer

✍ Werner, Michael E.; Cummings, Natalie D.; Sethi, Manish; Wang, Edina C.; Sukumar 📂 Article 📅 2013 🏛 Elsevier Science 🌐 English ⚖ 704 KB